Organogenesis Holdings Inc - ESG Rating & Company Profile powered by AI
If you are employed by Organogenesis Holdings Inc and you wish to use your ESG rating, please contact us. Jump to the end of this webpage for potential risks for Organogenesis Holdings Inc based on industry, location and marketcap. Detailed ESG assessment of Organogenesis Holdings Inc can be accessed by signing in.
Organogenesis Holdings Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 3.3; made up of an environmental score of 2.0, social score of 0.0 and governance score of 8.0.
3.3
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1234 | Quanterix Corp | 3.4 | Medium |
| 1234 | X4 Pharmaceuticals Inc | 3.4 | Medium |
| 1253 | Organogenesis Holdings Inc | 3.3 | Medium |
| 1253 | Calithera Biosciences Inc | 3.3 | Medium |
| 1253 | Cara Therapeutics Inc | 3.3 | Medium |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Organogenesis Holdings Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Organogenesis Holdings Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Organogenesis Holdings Inc report the average age of the workforce?
Sign up for free to unlockDoes Organogenesis Holdings Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Organogenesis Holdings Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Organogenesis Holdings Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Organogenesis Holdings Inc offer flexible work?
Sign up for free to unlockDoes Organogenesis Holdings Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Organogenesis Holdings Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Organogenesis Holdings Inc conduct supply chain audits?
Sign up for free to unlockDoes Organogenesis Holdings Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Organogenesis Holdings Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Organogenesis Holdings Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Organogenesis Holdings Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Organogenesis Holdings Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Organogenesis Holdings Inc disclose water use targets?
Sign up for free to unlockDoes Organogenesis Holdings Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Organogenesis Holdings Inc have a product recall in the last two years?
Sign up for free to unlockDoes Organogenesis Holdings Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Organogenesis Holdings Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Organogenesis Holdings Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Organogenesis Holdings Inc disclose parental leave metrics?
Sign up for free to unlockDoes Organogenesis Holdings Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Organogenesis Holdings Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Organogenesis Holdings Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Organogenesis Holdings Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Organogenesis Holdings Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Organogenesis Holdings Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Organogenesis Holdings Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Organogenesis Holdings Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Organogenesis Holdings Inc disclose its waste policy?
Sign up for free to unlockDoes Organogenesis Holdings Inc report according to TCFD requirements?
Sign up for free to unlockDoes Organogenesis Holdings Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Organogenesis Holdings Inc disclose energy use targets?
Sign up for free to unlockDoes Organogenesis Holdings Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Organogenesis Holdings Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Organogenesis Holdings Inc
These potential risks are based on the size, segment and geographies of the company.
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokines, and ECM proteins in the native tissue are preserved; Apligraf, a bioengineered living cell therapy that produce spectrum of cytokines and growth factors; Dermagraft, a bioengineered product that produces human collagen, ECM, proteins, and cytokines; NuShield, a wound covering tissue includes both amnion and chorion membranes for spongy/intermediate layer intact; PuraPly , a antimicrobial barrier that enables conformability and fluid drainage; and Novachor, an amniotic membrane wound covering in which viable cells, growth factors/cytokines, and ECM proteins are preserved. Its surgical and sports medicine products comprise NuCel, a dehydrated placental tissue surgically applied to the target tissue to support native healing; ReNu, a cryopreserved suspension used to support healing of soft tissues; and FiberOS and OCMP used as a bone void filler primarily in orthopedic and neurosurgical applications. The company's pipeline products include PuraPly XT and PuraPly MZ to treat chronic, acute, and open wounds; PuraForce, a bioengineered porcine collagen surgical matrix for use in soft tissue reinforcement applications; and TransCyte, a bioengineered tissue for the treatment of partial thickness burns. It serves hospitals, wound care centers, government facilities, ambulatory service centers, and physician office through direct sales force and independent agencies. The company was founded in 1985 and is headquartered in Canton, Massachusetts.